GTBP: GT Biopharma, Inc. Stock

by  •  • Comments Off on GTBP: GT Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.03
Enterprise Value ($M) 1.08
Book Value ($M) -1.67
Book Value / Share -0.75
Price / Book -3.01
NCAV ($M) -1.67
NCAV / Share -0.75
Price / NCAV -3.01

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.33
Return on Equity (ROE) -2.48

Liquidity (mrq)
Quick Ratio 0.72
Current Ratio 0.72

Balance Sheet (mrq) ($M)
Current Assets 4.23
Assets 4.23
Liabilities 5.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -14.36
Net Income -13.16
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -12.90
Cash from Investing 12.89
Cash from Financing 2.98

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-17 13G/A Cytovance Biologics Inc 9.80 -92.04
05-23 13G/A Bristol Investment Fund Ltd 8.80 -41.56

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-14 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-02-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 226 6,661 3.39
2025-04-16 4,688 11,577 40.49
2025-04-15 961 2,292 41.93

(click for more detail)

Similar Companies
GNPX – Genprex, Inc. GOVX – GeoVax Labs, Inc.
GRCE – Grace Therapeutics, Inc. GYRE – Gyre Therapeutics, Inc.
HCWB – HCW Biologics Inc.


Financial data and stock pages provided by
Fintel.io